Home page Home page

Lonquex
lipegfilgrastim

Package leaflet: Information for the user Lonquex 6 mg solution for injection in pre-filled syringe

lipegfilgrastim


Read all of this leaflet carefully before you start using this medicine because it contains important information for you.


What is in this leaflet


  1. What Lonquex is and what it is used for

  2. What you need to know before you use Lonquex

  3. How to use Lonquex

  4. Possible side effects

  5. How to store Lonquex

  6. Contents of the pack and other information


  1. What Lonquex is and what it is used for What Lonquex is

    Lonquex contains the active substance lipegfilgrastim. Lipegfilgrastim is a long-acting modified protein produced by biotechnology in bacteria called Escherichia coli. It belongs to a group of proteins called cytokines and is similar to a natural protein (granulocyte-colony stimulating factor [G-CSF]) produced by your own body.


    What Lonquex is used for

    Your doctor has prescribed Lonquex for you in order to reduce the duration of a condition called neutropenia (low white blood cell count) and the occurrence of febrile neutropenia (low white blood cell count with a fever). These can be caused by the use of cytotoxic chemotherapy (medicines that destroy rapidly-growing cells).


    How Lonquex works

    Lipegfilgrastim stimulates the bone marrow (the tissue where new blood cells are made) to produce more white blood cells. White blood cells are important as they help your body fight infection. These cells are very sensitive to the effects of chemotherapy which can cause the number of these cells in your body to decrease. If white blood cells fall to a low level, there may not be enough left in the body to fight bacteria and you may have an increased risk of infection.


  2. What you need to know before you use Lonquex Do not use Lonquex:

    • if you are allergic to lipegfilgrastim or any of the other ingredients of this medicine (listed in section 6).


      Warnings and precautions

      Talk to your doctor, pharmacist or nurse BEFORE using Lonquex

    • if you get left upper abdominal pain or pain at the tip of your shoulder. It could be a consequence of a spleen disorder (see section4 “Possible side effects”).

    • if you have a cough, fever and difficulty breathing. It could be a consequence of a pulmonary disorder (see section4 “Possible side effects”).

    • if you have sickle cell anaemia, which is an inherited disease characterised by sickle-shaped red blood cells.

    • if you have previously experienced allergic reactions to other medicines like this one (e.g. filgrastim, lenograstim or pegfilgrastim of the group of G-CSFs). There could be a risk of reacting to Lonquex too.


      Your doctor will carry out regular blood tests in order to monitor various blood components and their levels. Your doctor will also check your urine regularly as other medicines similar to this one (e.g. other granulocyte colony stimulating factors such as filgrastim, lenograstim or pegfilgrastim) can possibly harm the tiny filters inside your kidneys (glomerulonephritis; see section “4. Possible side effects”).


      Inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) has been reported rarely with other medicines like this one (e.g. filgrastim, lenograstim or pegfilgrastim of the group of G-CSFs). The symptoms can include fever, abdominal pain, malaise, back pain and increased inflammatory markers. Tell your doctor if you experience these symptoms.


      Children and adolescents

      Do not give this medicine to children and adolescents under 18 years of age because there is only limited experience in children to show that this medicine is safe and works in this age group.


      Other medicines and Lonquex

      Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.


      You will normally inject your dose of Lonquex approximately 24 hours after your last dose of chemotherapy at the end of each chemotherapy cycle.


      Pregnancy and breast-feeding

      Lonquex has not been tested in pregnant women. It is important to tell your doctor if you are pregnant, think you may be pregnant or are planning to have a baby, as the doctor may decide that you should not use this medicine.


      It is unknown whether the active substance in this medicine passes into the breast milk. You should therefore interrupt breast-feeding during treatment..


      Driving and using machines

      Lonquex has no or negligible influence on your ability to drive and use machines.


      Lonquex contains sorbitol and sodium

      This medicine contains 30 mg sorbitol in each pre-filled syringe.


      This medicine contains less than 1 mmol sodium (23 mg) per pre-filled syringe, that is to say essentially ‘sodium-free’.


  3. How to use Lonquex


Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.


What the recommended dose is

The recommended dose is one pre-filled syringe (6 mg lipegfilgrastim) once per chemotherapy cycle.

When to use Lonquex

This medicine should be given approximately 24 hours after your last dose of chemotherapy at the end of each chemotherapy cycle.


How are the injections given?

This medicine is given as an injection using a pre-filled syringe. The injection is given into the tissue just under the skin (subcutaneous injection).


Your doctor may suggest that you learn how to inject yourself with this medicine. Your doctor or nurse will give you instructions on how to do this. Do not attempt to give Lonquex to yourself without this training. Information required for using the pre-filled syringe can be found under “Information for injecting yourself”. Proper treatment of your disease, however, requires close and constant

co-operation with your doctor.


Information for injecting yourself


This section contains information on how to give yourself an injection of Lonquex under the skin. It is important that you do not try to give yourself the injection unless you have received special training from your doctor or nurse. If you are not sure about giving yourself the injection or you have any questions, please ask your doctor or nurse for help.


How Lonquex is used

You will need to give yourself the injection into the tissue just under the skin. This is known as a subcutaneous injection.


Equipment that you need

To give yourself an injection into the tissue under the skin you will need:


What Lonquex looks like and contents of the pack

Lonquex is a solution for injection (injection) in pre-filled syringe with a fixed injection needle in a blister. Lonquex is a clear and colourless solution. Each pre-filled syringe contains 0.6 ml solution.


Lonquex is available in packs containing 1 and 4 pre-filled syringes with safety device or 1 pre-filled syringe without safety device.


Not all pack sizes may be marketed.


Marketing Authorisation Holder

Teva B.V. Swensweg 5

2031 GA Haarlem Netherlands


Manufacturer

Teva Biotech GmbH Dornierstraße 10

89079 Ulm

Germany


Merckle GmbH, Graf-Arco-Straße 3

89079 Ulm

Germany


For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:


België/Belgique/Belgien

Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373

Lietuva

UAB Teva Baltics Tel: +370 52660203


България

Тева Фарма ЕАД Teл: +359 24899585

Luxembourg/Luxemburg

Teva Pharma Belgium N.V./S.A./AG Belgique/Belgien

Tél/Tel: +32 38207373

Česká republika

Teva Pharmaceuticals CR, s.r.o. Tel: +420 251007111

Magyarország

Teva Gyógyszergyár Zrt. Tel: +36 12886400


Danmark

Teva Denmark A/S Tlf: +45 44985511

Malta

Teva Pharmaceuticals Ireland L-Irlanda

Tel: +44 2075407117


Deutschland

TEVA GmbH

Tel: +49 73140208

Nederland

Teva Nederland B.V. Tel: +31 8000228400


Eesti

UAB Teva Baltics Eesti filiaal Tel: +372 6610801

Norge

Teva Norway AS Tlf: +47 66775590


Ελλάδα

Specifar A.B.E.E.

Τηλ: +30 2118805000

Österreich

ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970070


España

Teva Pharma, S.L.U. Tel: +34 913873280

Polska

Teva Pharmaceuticals Polska Sp. z o.o. Tel: +48 223459300


France

Teva Santé

Tél: +33 155917800

Portugal

Teva Pharma - Produtos Farmacêuticos, Lda. Tel: +351 214767550


Hrvatska

Pliva Hrvatska d.o.o. Tel: +385 13720000

România

Teva Pharmaceuticals S.R.L. Tel: +40 212306524


Ireland

Teva Pharmaceuticals Ireland Tel: +44 2075407117

Slovenija

Pliva Ljubljana d.o.o. Tel: +386 15890390


Ísland

Alvogen ehf.

Sími: +354 5222900

Slovenská republika

TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 257267911


Italia

Teva Italia S.r.l. Tel: +39 028917981

Suomi/Finland

Teva Finland Oy

Puh/Tel: +358 201805900


Κύπρος

Specifar A.B.E.E.

Ελλάδα

Τηλ: +30 2118805000

Sverige

Teva Sweden AB Tel: +46 42121100


Latvija

UAB Teva Baltics filiāle Latvijā

Tel: +371 67323666

United Kingdom (Northern Ireland)

Teva Pharmaceuticals Ireland Ireland

Tel: +44 2075407117

This leaflet was last revised in {month YYYY}.